Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Cencora's share price for the quarter that ended in Dec. 2023 was $205.38. Cencora's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 199 Mil. Therefore, Cencora's market cap for the quarter that ended in Dec. 2023 was $40,966 Mil.
Cencora's quarterly market cap
declined
from Jun. 2023 ($38,892 Mil) to Sep. 2023 ($36,141 Mil) but then
increased
from Sep. 2023 ($36,141 Mil) to Dec. 2023 ($40,966 Mil).
Cencora's annual market cap
increased
from Sep. 2021 ($24,856 Mil) to Sep. 2022 ($27,906 Mil) and
increased
from Sep. 2022 ($27,906 Mil) to Sep. 2023 ($36,141 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Cencora's Enterprise Value for Today is $49,193 Mil.
Cencora Market Cap Historical Data
The historical data trend for Cencora's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Cencora Annual Data
Trend
Sep14
Sep15
Sep16
Sep17
Sep18
Sep19
Sep20
Sep21
Sep22
Sep23
Market Cap
17,022.63
19,793.58
24,856.23
27,905.59
36,140.68
Cencora Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
Market Cap
33,510.87
32,408.03
38,891.83
36,140.68
40,965.51
Competitive Comparison
For the Medical Distribution subindustry, Cencora's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cencora Market Cap Distribution
For the Medical Distribution industry and Healthcare sector, Cencora's Market Cap distribution charts can be found below:
* The bar in red indicates where Cencora's Market Cap falls into.
Cencora Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Cencora's Market Cap for the fiscal year that ended in Sep. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cencora (NYSE:COR) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Cencora Market Cap Related Terms
Thank you for viewing the detailed overview of Cencora's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the U.S. pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
COR has been successfully added to your 